咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献

馆藏范围

  • 2 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 农学
    • 1 篇 兽医学
  • 1 篇 医学
    • 1 篇 临床医学

主题

  • 1 篇 ramucirumab
  • 1 篇 myofibroblast
  • 1 篇 line
  • 1 篇 cell
  • 1 篇 lipopolysacchari...
  • 1 篇 sorafenib
  • 1 篇 mouse
  • 1 篇 colon
  • 1 篇 lenvatinib
  • 1 篇 hepatocellular c...

机构

  • 1 篇 department of he...
  • 1 篇 department of ga...
  • 1 篇 department of ga...
  • 1 篇 gastroenterology...
  • 1 篇 department of ga...
  • 1 篇 department of ga...
  • 1 篇 department of ga...
  • 1 篇 division of gast...
  • 1 篇 division of gast...
  • 1 篇 department of ga...
  • 1 篇 hepato-biliary c...
  • 1 篇 department of ve...
  • 1 篇 laboratory of ve...
  • 1 篇 center of gastro...
  • 1 篇 department of ga...
  • 1 篇 department of ga...
  • 1 篇 department of ga...
  • 1 篇 department of ga...
  • 1 篇 department of in...
  • 1 篇 department of ga...

作者

  • 1 篇 toru ishikawa
  • 1 篇 norio itokawa
  • 1 篇 kazuhiro nouso
  • 1 篇 ei itobayashi
  • 1 篇 chikara ogawa
  • 1 篇 kunihiko tsuji
  • 1 篇 kazuya kariyama
  • 1 篇 yohei koizumi
  • 1 篇 koichi sato
  • 1 篇 hironori ochi
  • 1 篇 koichi takaguchi
  • 1 篇 shinichiro nakam...
  • 1 篇 noritomo shimada
  • 1 篇 shinya fukunishi
  • 1 篇 kazuto tajiri
  • 1 篇 michitaka imai
  • 1 篇 yoichi hiasa
  • 1 篇 toshifumi tada
  • 1 篇 takashi ohama
  • 1 篇 masashi hirooka

语言

  • 2 篇 英文
检索条件"作者=Takashi Ohama"
2 条 记 录,以下是1-10 订阅
排序:
Establishment of mouse intestinal myofibroblast cell lines
收藏 引用
World Journal of Gastroenterology 2013年 第17期19卷 2629-2637页
作者: Hideyoshi Kawasaki takashi ohama Masatoshi Hori Koichi Sato Laboratory of Veterinary Pharmacology Joint Faculty of Veterinary Medicine Yamaguchi University Department of Veterinary Pharmacology Graduate School of Agriculture and Life Sciences the University of Tokyo
AIM:To establish novel intestinal myofibroblast (IMF) cell lines from mouse colonic mucosa and investigate their biological characters. METHODS:Primary IMFs were isolated from mucosal tissues of mouse colon that was d... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma
收藏 引用
Gastroenterology Report 2021年 第2期9卷 133-138,I0002页
作者: Atsushi Hiraoka takashi Kumada Toshifumi Tada Chikara Ogawa Joji Tani Shinya Fukunishi Masanori Atsukawa Masashi Hirooka Kunihiko Tsuji Toru Ishikawa Koichi Takaguchi Kazuya Kariyama Ei Itobayashi Kazuto Tajiri Noritomo Shimada Hiroshi Shibata Hironori Ochi Kazuhito Kawata Hidenori Toyoda Hideko ohama Kazuhiro Nouso Akemi Tsutsui Takuya Nagano Norio Itokawa Korenobu Hayama Taeang Arai Michitaka Imai Yohei Koizumi Shinichiro Nakamura Kojiro Michitaka Yoichi Hiasa Masatoshi Kudo Gastroenterology Center Ehime Prefectural Central HospitalEhimeJapan Department of Gastroenterology and Hepatology Ogaki Municipal HospitalGifuJapan Department of Internal Medicine Himeji Red Cross HospitalHyogoJapan Department of Gastroenterology and Hepatology Takamatsu Red Cross HospitalTakamatsuJapan Department of Gastroenterology and Hepatology Kagawa universityKagawaJapan Department of Gastroenterology Osaka Medical CollegeOsakaJapan Division of Gastroenterology and Hepatology Department of Internal MedicineNippon Medical SchoolTokyoJapan Department of Gastroenterology and Metabology Ehime University Graduate School of MedicineEhimeJapan Center of Gastroenterology Teine Keijinkai HospitalSapporoJapan Department of Gastroenterology Saiseikai Niigata HospitalNiigataJapan Department of Hepatology Kagawa Prefectural Central HospitalTakamatsuJapan Department of Gastroenterology Okayama City HospitalOkayamaJapan Department of Gastroenterology Asahi General HospitalAsahiJapan Department of Gastroenterology Toyama University HospitalToyamaJapan Division of Gastroenterology and Hepatology Otakanomori HospitalKashiwaJapan Department of Gastroenterology Tokushima Prefectural Central HospitalTokushimaJapan Hepato-biliary Center Matsuyama Red Cross HospitalMatsuyamaJapan Department of Hepatology Hamamatsu University School of MedicineHamamatsuJapan Department of Gastroenterology Kindai UniversityOsakaJapan
Background:Lenvatinib is used for unresectable hepatocellular carcinoma(u-HCC)as first-line,as well as second-and third-line therapy in *** evaluated the therapeutic efficacy of newly developed ramucirumab when given ... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论